Vincerx Pharma (VINC) Competitors $0.03 +0.00 (+6.67%) As of 10/17/2025 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VINC vs. PTPI, BPTSY, BPTH, NKGN, BON, NCNA, SYRS, PBLA, SCPS, and VRPXShould you be buying Vincerx Pharma stock or one of its competitors? The main competitors of Vincerx Pharma include Petros Pharmaceuticals (PTPI), Biophytis (BPTSY), Bio-Path (BPTH), NKGen Biotech (NKGN), Bon Natural Life (BON), NuCana (NCNA), Syros Pharmaceuticals (SYRS), Panbela Therapeutics (PBLA), Scopus BioPharma (SCPS), and Virpax Pharmaceuticals (VRPX). These companies are all part of the "pharmaceutical products" industry. Vincerx Pharma vs. Its Competitors Petros Pharmaceuticals Biophytis Bio-Path NKGen Biotech Bon Natural Life NuCana Syros Pharmaceuticals Panbela Therapeutics Scopus BioPharma Virpax Pharmaceuticals Petros Pharmaceuticals (NASDAQ:PTPI) and Vincerx Pharma (NASDAQ:VINC) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends. Which has better valuation & earnings, PTPI or VINC? Petros Pharmaceuticals has higher revenue and earnings than Vincerx Pharma. Vincerx Pharma is trading at a lower price-to-earnings ratio than Petros Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPetros Pharmaceuticals$5.11M0.14-$8.16M-$52.910.00Vincerx PharmaN/AN/A-$40.16M-$20.600.00 Does the media prefer PTPI or VINC? In the previous week, Vincerx Pharma had 1 more articles in the media than Petros Pharmaceuticals. MarketBeat recorded 1 mentions for Vincerx Pharma and 0 mentions for Petros Pharmaceuticals. Vincerx Pharma's average media sentiment score of 1.00 beat Petros Pharmaceuticals' score of 0.00 indicating that Vincerx Pharma is being referred to more favorably in the news media. Company Overall Sentiment Petros Pharmaceuticals Neutral Vincerx Pharma Positive Which has more volatility & risk, PTPI or VINC? Petros Pharmaceuticals has a beta of 1.64, suggesting that its share price is 64% more volatile than the S&P 500. Comparatively, Vincerx Pharma has a beta of 1.78, suggesting that its share price is 78% more volatile than the S&P 500. Is PTPI or VINC more profitable? Petros Pharmaceuticals' return on equity of -78.22% beat Vincerx Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Petros PharmaceuticalsN/A -78.22% -23.50% Vincerx Pharma N/A -248.33%-132.73% Do insiders and institutionals believe in PTPI or VINC? 12.3% of Petros Pharmaceuticals shares are owned by institutional investors. Comparatively, 44.0% of Vincerx Pharma shares are owned by institutional investors. 12.3% of Petros Pharmaceuticals shares are owned by company insiders. Comparatively, 15.6% of Vincerx Pharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryVincerx Pharma beats Petros Pharmaceuticals on 7 of the 11 factors compared between the two stocks. Get Vincerx Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for VINC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VINC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart VINC vs. The Competition Export to ExcelMetricVincerx PharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$167K$1.08B$6.20B$10.53BDividend YieldN/A4.84%5.70%4.83%P/E Ratio0.001.3285.7027.13Price / SalesN/A31.08585.75179.61Price / CashN/A17.6337.1060.81Price / Book0.008.0712.236.52Net Income-$40.16M-$7.36M$3.33B$276.93M7 Day PerformanceN/A-1.73%1.17%1.93%1 Month PerformanceN/A28.41%6.85%2.19%1 Year PerformanceN/A-12.09%58.93%34.62% Vincerx Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VINCVincerx Pharma1.8289 of 5 stars$0.03+6.7%N/A-99.6%$167KN/A0.0060Short Interest ↓Gap UpPTPIPetros PharmaceuticalsN/A$0.02-0.9%N/A-99.7%$704K$5.11M0.0020Gap DownBPTSYBiophytisN/A$2.00flatN/A-41.5%$702KN/A0.0030BPTHBio-Path0.6389 of 5 stars$0.07+3.2%N/A-94.1%$629KN/A0.0010Short Interest ↑Gap DownNKGNNKGen BiotechN/A$0.01+400.0%N/A-95.0%$449KN/A0.00N/AGap UpBONBon Natural Life1.2536 of 5 stars$2.14+1.9%N/AN/A$350K$23.84M0.00100News CoveragePositive NewsShort Interest ↓NCNANuCana1.9283 of 5 stars$5.78+8.4%N/A-98.7%$160KN/A-0.0130News CoverageGap DownSYRSSyros Pharmaceuticals3.6486 of 5 stars$0.01flat$1.00+19,900.0%-100.0%$134K$386K0.00120PBLAPanbela Therapeutics0.1103 of 5 stars$0.01+0.9%N/A-93.7%$54KN/A0.006News CoverageSCPSScopus BioPharmaN/A$0.00flatN/AN/A$42KN/A0.009VRPXVirpax Pharmaceuticals0.2156 of 5 stars$0.02+90.9%N/A-99.9%$26KN/A0.007Gap Up Related Companies and Tools Related Companies PTPI Competitors BPTSY Competitors BPTH Competitors NKGN Competitors BON Competitors NCNA Competitors SYRS Competitors PBLA Competitors SCPS Competitors VRPX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VINC) was last updated on 10/19/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vincerx Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vincerx Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VINC Stock Alerts